NeuroOne Medical Technologies (NMTC) Short Interest Ratio & Short Volume $0.65 +0.05 (+8.04%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$0.66 +0.01 (+0.92%) As of 04/25/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroOne Medical Technologies Short Interest DataNeuroOne Medical Technologies (NMTC) has a short interest of 407,100 shares, representing 1.01% of the float (the number of shares available for trading by the public). This marks a 175.44% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 174,339 shares to cover all short positions.Current Short Interest407,100 sharesPrevious Short Interest147,800 sharesChange Vs. Previous Month+175.44%Dollar Volume Sold Short$219,834.00Short Interest Ratio1.4 Days to CoverLast Record DateApril 15, 2025Outstanding Shares47,386,000 sharesFloat Size40,490,000 sharesShort Percent of Float1.01%Today's Trading Volume317,463 sharesAverage Trading Volume174,339 sharesToday's Volume Vs. Average182% Short Selling NeuroOne Medical Technologies? Sign up to receive the latest short interest report for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNMTC Short Interest Over TimeNMTC Days to Cover Over TimeNMTC Percentage of Float Shorted Over Time NeuroOne Medical Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025407,100 shares $219,834.00 +175.4%1.0%1.4 $0.54 3/31/2025147,800 shares $125,659.56 +10.3%0.4%0.6 $0.85 3/15/2025134,000 shares $144,720.00 -34.4%0.5%0.6 $1.08 2/28/2025204,300 shares $227,794.50 +7.1%0.8%0.8 $1.12 2/15/2025190,800 shares $228,960.00 +43.4%0.7%0.8 $1.20 1/31/2025133,100 shares $153,065.00 +40.1%0.5%0.6 $1.15 1/15/202595,000 shares $101,650.00 +35.1%0.4%0.4 $1.07 12/31/202470,300 shares $58,060.77 -37.1%0.3%0.4 $0.83 12/15/2024111,800 shares $84,990.36 +17.1%0.4%0.8 $0.76 11/30/202495,500 shares $59,496.50 -10.8%0.4%0.9 $0.62 Get the Latest News and Ratings for NMTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024107,100 shares $76,148.10 -12.8%0.4%1.2 $0.71 10/31/2024122,800 shares $119,116.00 -4.4%0.5%1.9 $0.97 10/15/2024128,400 shares $121,980.00 -12.0%0.5%2.4 $0.95 9/30/2024145,900 shares $144,441.00 +2.8%0.5%2.7 $0.99 9/15/2024141,900 shares $117,777.00 +9.0%0.5%2 $0.83 8/31/2024130,200 shares $103,691.28 +15.8%0.5%1.6 $0.80 8/15/2024112,400 shares $82,052.00 +81.6%0.4%1.1 $0.73 7/31/202461,900 shares $46,425.00 -44.8%0.3%0.5 $0.75 7/15/2024112,200 shares $111,078.00 -44.8%0.5%0.8 $0.99 6/30/2024203,300 shares $162,640.00 +9.2%0.9%1.4 $0.80 6/15/2024186,100 shares $177,558.20 -35.5%0.8%0.9 $0.95 5/31/2024288,700 shares $268,462.13 +11.3%1.2%1.5 $0.93 5/15/2024259,500 shares $275,070.00 -6.9%1.1%1.3 $1.06 4/30/2024278,600 shares $314,818.00 -9.7%1.3%1.4 $1.13 4/15/2024308,500 shares $345,520.00 -15.6%1.4%1.6 $1.12 3/31/2024365,300 shares $438,360.00 +133.0%1.7%1.9 $1.20 3/15/2024156,800 shares $166,208.00 +8.7%0.7%0.8 $1.06 2/29/2024144,200 shares $174,482.00 +67.1%0.7%0.7 $1.21 2/15/202486,300 shares $90,615.00 +7.6%0.4%0.5 $1.05 1/31/202480,200 shares $100,250.00 -38.8%0.4%0.4 $1.25 1/15/2024131,000 shares $180,780.00 +22.2%0.6%0.6 $1.38 12/31/2023107,200 shares $169,376.00 -43.3%0.5%0.5 $1.58 12/15/2023189,000 shares $289,170.00 +30.5%0.9%0.9 $1.53 11/30/2023144,800 shares $209,960.00 -1.3%0.7%0.9 $1.45 11/15/2023146,700 shares $211,248.00 -30.1%0.7%1.1 $1.44 10/31/2023210,000 shares $188,979.00 +115.6%1.0%1.8 $0.90 10/15/202397,400 shares $85,858.10 -1.6%0.4%0.7 $0.88 9/30/202399,000 shares $88,149.60 -26.9%0.5%0.7 $0.89 9/15/2023135,500 shares $143,630.00 +53.6%0.6%0.9 $1.06 8/31/202388,200 shares $75,014.10 -56.4%0.4%0.5 $0.85Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/15/2023202,200 shares $212,310.00 -28.4%0.9%1.2 $1.05 7/31/2023282,400 shares $288,048.00 +29.5%1.3%1.6 $1.02 7/15/2023218,100 shares $434,019.00 +135.8%1.4%1.2 $1.99 6/30/202392,500 shares $111,000.00 -30.5%0.6%0.4 $1.20 6/15/2023133,000 shares $158,270.00 +13.4%0.9%0.7 $1.19 5/31/2023117,300 shares $141,933.00 +5.0%0.8%0.6 $1.21 5/15/2023111,700 shares $159,731.00 -31.5%0.7%0.5 $1.43 4/30/2023163,000 shares $251,020.00 -58.8%1.1%0.8 $1.54 4/15/2023395,900 shares $684,946.59 +521.5%2.7%2.2 $1.73 3/31/202363,700 shares $102,557.00 +74.5%0.4%0.4 $1.61 3/15/202336,500 shares $62,415.00 -66.2%0.3%0.3 $1.71 2/28/2023108,000 shares $173,880.00 -34.2%0.7%0.9 $1.61 2/15/2023164,200 shares $284,066.00 -26.6%1.1%0.9 $1.73 1/31/2023223,800 shares $324,510.00 -19.1%1.6%0.8 $1.45 1/15/2023276,600 shares $354,048.00 -4.7%1.9%1 $1.28 12/30/2022290,300 shares $348,360.00 -41.3%2.0%1.1 $1.20 12/15/2022494,700 shares $1.30 million +18.0%3.4%1.9 $2.63 11/30/2022419,100 shares $590,931.00 +1,487.5%2.9%1.7 $1.41 11/15/202226,400 shares $22,907.28 -35.1%0.2%0.1 $0.87 10/31/202240,700 shares $39,678.43 -45.2%0.3%0.4 $0.97 10/15/202274,200 shares $118,720.00 -23.6%0.5%0.4 $1.60 9/30/202297,100 shares $164,099.00 +83.2%0.7%0.5 $1.69 9/15/202253,000 shares $113,420.00 -2.4%0.4%0.3 $2.14 8/31/202254,300 shares $138,465.00 -0.4%0.4%0.3 $2.55 8/15/202254,500 shares $105,730.00 +59.4%0.4%0.3 $1.94 7/31/202234,200 shares $40,356.00 +3.0%0.2%0.2 $1.18 7/15/202233,200 shares $31,958.32 -19.6%0.2%0.4 $0.96 5/14/20211,300 shares $8,385.00 No ChangeN/A0.1 $6.45 4/30/20211,300 shares $0.00 No ChangeN/A0.1 $0.00 3/31/20218,900 shares $21,983.00 +7.2%N/A0.1 $2.47 3/15/20218,300 shares $21,613.20 -51.2%N/A0 $2.60 2/26/202117,000 shares $49,130.00 +71.7%N/A0.1 $2.89 2/12/20219,900 shares $35,640.00 +76.8%N/A0 $3.60 1/29/20215,600 shares $11,536.00 +133.3%N/A0 $2.06 1/15/202113,000 shares $18,200.00 +154.9%N/A0.1 $1.40 12/31/20203,300 shares $5,544.00 -74.6%N/A0 $1.68 12/15/202013,000 shares $17,160.00 +154.9%N/A0.1 $1.32 11/30/20205,100 shares $5,202.00 -21.5%N/A0.1 $1.02 11/15/20206,500 shares $6,175.00 -59.4%N/A0.1 $0.95 10/30/202016,000 shares $16,000.00 -22.3%N/A0.2 $1.00 10/15/202020,600 shares $27,027.20 -9.3%N/A0.2 $1.31 9/30/202022,700 shares $29,169.50 +5.6%N/A0.2 $1.29 9/15/202021,500 shares $23,865.00 +33.5%N/A0.3 $1.11 8/31/202016,100 shares $27,531.00 +49.1%N/A1.4 $1.71 8/14/202010,800 shares $18,468.00 +2.9%N/A0.6 $1.71 7/31/202010,500 shares $18,900.00 -24.5%N/A0.2 $1.80 7/15/202013,900 shares $19,460.00 -5.4%N/A1.2 $1.40 6/30/202014,700 shares $21,021.00 -3.9%N/A0.6 $1.43 6/15/202015,300 shares $21,420.00 -6.1%N/A0.6 $1.40 5/29/202016,300 shares $24,287.00 +6.5%N/A0.6 $1.49Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 5/15/202015,300 shares $27,540.00 -1.9%N/A1 $1.80 4/30/202015,600 shares $34,320.00 +2.0%N/A1 $2.20 NMTC Short Interest - Frequently Asked Questions What is NeuroOne Medical Technologies' current short interest? Short interest is the volume of NeuroOne Medical Technologies shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 147,800 shares of NMTC short. 0.36% of NeuroOne Medical Technologies' shares are currently sold short. Learn More on NeuroOne Medical Technologies' current short interest. What is a good short interest ratio for NeuroOne Medical Technologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NMTC shares currently have a short interest ratio of 1.0. Learn More on NeuroOne Medical Technologies's short interest ratio. Which institutional investors are shorting NeuroOne Medical Technologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of NeuroOne Medical Technologies: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for NeuroOne Medical Technologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.36% of NeuroOne Medical Technologies' floating shares are currently sold short. Is NeuroOne Medical Technologies' short interest increasing or decreasing? NeuroOne Medical Technologies saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 147,800 shares, an increase of 10.3% from the previous total of 134,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroOne Medical Technologies' float size? NeuroOne Medical Technologies currently has issued a total of 47,386,000 shares. Some of NeuroOne Medical Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroOne Medical Technologies currently has a public float of 41,090,000 shares. How does NeuroOne Medical Technologies' short interest compare to its competitors? 0.36% of NeuroOne Medical Technologies' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to NeuroOne Medical Technologies: Lucid Diagnostics Inc. (4.15%), Monogram Orthopaedics, Inc. (1.54%), Microbot Medical Inc. (21.14%), Sensus Healthcare, Inc. (6.18%), FONAR Co. (0.37%), Inovio Pharmaceuticals, Inc. (17.57%), Zynex, Inc. (21.28%), IceCure Medical Ltd (1.00%), Cytosorbents Co. (3.43%), Vivani Medical, Inc. (1.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short NeuroOne Medical Technologies stock? Short selling NMTC is an investing strategy that aims to generate trading profit from NeuroOne Medical Technologies as its price is falling. NMTC shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroOne Medical Technologies? A short squeeze for NeuroOne Medical Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NMTC, which in turn drives the price of the stock up even further. How often is NeuroOne Medical Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NMTC, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Lucid Diagnostics Short Interest Data Monogram Orthopaedics Short Interest Data Microbot Medical Short Interest Data Sensus Healthcare Short Interest Data FONAR Short Interest Data Inovio Pharmaceuticals Short Interest Data Zynex Short Interest Data IceCure Medical Short Interest Data Cytosorbents Short Interest Data Vivani Medical Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NMTC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMTC Stock Free NMTC Stock Alerts